AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Is the FDA Too Cautious?
Open to Debate
The Importance of Accelerated Approval in Drug Development
I think what keeps the biotech and pharma industry from investing in a lot of new breakthrough drugs is the regulatory hurdles. It's too expensive, takes too long, and therefore they just don't put the money in. I would say we're technically on the third wave of AI for people who have been in the industry for a long time. At our company, we use it to create digital twins, which are replicas of humans from the genes up that we use to discover new drugs or simulate drug treatment. And so, I think we're going to start to see AI play a bigger role in clinical trial design.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode